Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Publication Name : Lancet Diabetes and Endocrinology

DOI : 10.1016/S2213-8587(23)00253-X

Date : December 2023


Publication URL
https://www.scopus.com/record/display.uri?eid=2-s2.0-85176327080&origin=resultslist&sort=plf-f
Type
Journal
ISSN
22138587
Volume
11
Page
905-914